アブストラクト
Japanese
Title | 周期性嘔吐症候群の発作期におけるアトロピン硫酸塩の有効性 |
---|---|
Subtitle | 原著 |
Authors | 一木美穂, 近藤宏樹, 井上智弘, 南方俊祐, 舩戸契, 虫明聡太郎 |
Authors (kana) | |
Organization | 近畿大学奈良病院 小児科 |
Journal | 日本小児栄養消化器肝臓学会雑誌 |
Volume | 35 |
Number | 2 |
Page | 63-69 |
Year/Month | 2021 / |
Article | 原著 |
Publisher | 日本小児栄養消化器肝臓学会 |
Abstract | 「要旨」周期性嘔吐症候群 (CVS) の治療目標は, 1) 発作間欠期間の延長, 2) 発作期間の短縮, および3) 発作症状の軽減にある. 1) に対しては複数の薬剤の有効性が報告されているが, 2, 3) に対する薬剤の有効性を示した報告はない. 今回, 当科で診療中のCVS10症例に対して, 発作初期にアトロピン硫酸塩の静注, または経口・経腸投与を行い, 本人または保護者への質問票により効果の有無を評価した. 静注は9例中8例で, 経口・経胃瘻投与は10例中9例で有効であった. 5例では発作期間の短縮, または発作回避が可能なときがあった. 有効例における効果持続はいずれも5〜6時間以下であった. CVSにおける唾液・胃液の分泌亢進と胃の蠕動亢進, 痙性腹痛は, コリン作動神経の過剰興奮を背景とする. アトロピン硫酸塩は短時間ながら明確にこれを抑制し, 発作初期の症状の軽減及び発作回避に有用であると考えられた. |
Practice | 臨床医学:内科系 |
Keywords | 周期性嘔吐症候群, 発作期, アトロピン硫酸塩 |
English
Title | Atropine sulfate is effective for attacks of cyclic vomiting syndrome |
---|---|
Subtitle | |
Authors | Miho Ichiki, Hiroki Kondou, Tomohiro Inoue, Shunsuke Minakata, Kei Funato, Sotaro Mushiake |
Authors (kana) | |
Organization | Department of pediatrics, Kindai university Nara Hospital |
Journal | Japanese Journal of Pediatric Gastroenterology, Hepatology and Nutrition |
Volume | 35 |
Number | 2 |
Page | 63-69 |
Year/Month | 2021 / |
Article | Original article |
Publisher | The Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition |
Abstract | The goals for treatment of cyclic vomiting syndrome (CVS) are prolongation of intermittent attack period, shortening of attack duration or termination, and reduction of attack symptoms. The effectiveness of multiple drugs has been reported for prolongation of intermittent attack period, but there are few reports of treatments that can reduce symptoms or terminate each attack. Ten CVS patients undergoing medical care at our department were treated with administration of atropine sulfate (AS) intravenously, orally or enterally at the initiation of attack. The effectiveness was evaluated by a questionnaire to the patients or parents. Intravenous administration was effective in 8 of 10 cases. Oral and enteral administration were also effective in 9 out of 10 cases. In 5 cases, the attack period was shortened or progression of attacks were sometimes avoided. In all the effective cases, the effect duration was 5 to 6 hours or less. Gastrointestinal symptoms in CVS are salivary and gastric juice secretion, increased gastric peristalsis, and spastic abdominal pain, with a background of hyperexcitation of cholinergic nerves. AS was clearly effective in suppressing these events in a short time. Administration of AS in the early phase of CVS attacks was thought to be useful in reducing symptoms and avoiding the progression of attacks. |
Practice | Clinical internal medicine |
Keywords |
- 全文ダウンロード: 従量制、基本料金制の方共に770円(税込) です。
参考文献
- 1) 小児慢性特定疾病情報センター 慢性消化器疾患 > 大分類:周期性嘔吐症候群 https://www.shouman.jp/disease/details/12_03_013/
- 2) Li BUK:Managing cyclic vomiting syndrome in children:beyond the guidelines. Eur J Pediatr 2018;177:1435-1442.
- 3) 埜中征哉, 長利伸一, 後藤雄一:目で見る小児神経-MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes)-. 小児科臨床 1994;47:2423-2426.
- 4) P Rinaldo:Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. Dig Dis Sci 1999;44:97S-102S.
- 5) 佐藤 保, 鈴木祐吉, 内潟安子, 舟橋 隆, 武藤一彦, 上棚直人, 京谷征三:周期性ACTH-ADH分泌過剰症5例の内分泌学的検討:周期性嘔吐症との異同に関する考察. 日児誌 1984;88:2468-2478.
残りの20件を表示する
- 6) 佐藤 保, 五十嵐登:周期性ACTH・ADH分泌過剰症の病因:カテコールアミンとプロスタグランディン E2の動態, 日内分泌会誌 1988:64:907-907.
- 7) Sato T:Prevalence of syndrome of periodic ACTHADH discharge in Japan. Clin Pediatr Endocrinol 1993;2:7-12.
- 8) Venkatesan T, Prieto T, Barboi A, Li B, Schroeder A, Hogan W, Ananthakrishnan A, Jaradeh S:Autonomic nerve function in adults with cyclic vomiting syndrome:a prospective study. Neurogastroenterol Motil 2010;22:1303-1307.
- 9) Tache Y:Cyclic vomiting syndrome:the corticotropin-releasing-factor hypothesis. Dig Dis Sci 1999;44:79S-86S.
- 10) Slutsker B, Konichezky A, Gothelf D:Breaking the cycle:cognitive behavioral therapy and biofeedback training in a case of cyclic vomiting syndrome. Psychol Health Med 2010;15:625-31.
- 11) Headache Classification Subcommittee of the International Headache Society:The International Classification of Headache Disorders:2nd edition. Cephalalgia 2004;24:1-160.
- 12) Li BUK, Lefevre F, Chelimsky GG, Boles RG, Nelson SP, Lewis DW, Linder SL, Issenman RM, Rudolph CD:North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2008;47:379-393.
- 13) Badihian N, Saneian H, Badihian S, Yaghini O:Prophylactic Therapy of Cyclic Vomiting Syndrome in Children:Comparison of Amitriptyline and Cyproheptadine:A Randomized Clinical Trial. Am J Gastroenterol 2018;113:135-140.
- 14) Hikita T, Kodama H, Nakamoto N, Kaga F, Amakata K, Ogita K, Kaneko S, Fujii Y, Yanagawa Y:Effective prophylactic therapy for cyclic vomiting syndrome in children using valproate. Brain Dev 2009;31:411-413.
- 15) Nagita A, Yamaguchi J, Amemoto K, et al. Management and ultrasonographic appearance of infantile hypertrophic pyloric stenosis with intravenous atropine sulfate, J Pediatr Gastroenterol Nutr 1996;23:172-177.
- 16) 公益社団法人日本麻酔科学会:麻酔薬およひ麻酔関連薬使用ガイドライン 第3版, 2009:https://anesth.or.jp/files/pdf/circulating_agonist_20190905.pdf(2020年6月8日アクセス)
- 17) 小笠原弘子, 篠原耕一, 山下茂樹, 横田喜美夫, 阿部政則. 坂 康雄. アトロピン前投薬の効果の検討. 日臨麻会誌 1987;7:330-335.
- 18) 西野淳司, 飴本完二, 山口 仁, 他:乳児肥厚性幽門狭窄症に対する硫酸アトロピン経口投与療法の検討. 日小児栄消病会誌 1993;7:151-154.
- 19) 名木田章, 森本高広, 西野淳司, 他:乳児肥厚性幽門狭窄症に対する硫酸アトロピン静注投与療法. 日児誌 1994;98:878-882.
- 20) Dias BLS, Fernandes AR, Filho HSM:Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy. Arq Neuropsiquiatr 2017;75:282-287.
- 21) Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M:Treatment of sialorrhea with glycopyrrolate:a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000;154:1214-8.
- 22) Zeller RS, Davidson J, Lee HM, Cavanaugh PF:Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions. Ther Clin Risk Manag 2012;8:25-32.
- 23) Montero AM, Posse JL, Carmona IT, Feijoo JF, Dios PD:Control of droolin using transdermal scopolamine skin patches:a case report. Med Oral Patol Oral Cir Bucal 2008;13:E27-30.
- 24) Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP:Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 1989:31(3):309-19.
- 25) Carranza-del Rio J, Clegg NJ, Moore A, Delgado MR:Use of trihexyphenidyl in children with cerebral palsy. Pediatr Neurol 2011;44:202-6.